Cedric Francois insider trades
Open-market stock purchases and sales by Cedric Francois, Chief Executive Officer at Apellis Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 16, 2018.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $433K |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $3.8M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $5.6M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $4.1M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $6M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $9.1M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $6.7M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $6.9M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $7M |
Companies traded
- APLS Apellis Pharmaceuticals, Inc: 64 sales, last May 14, 2026